BlackRock »

BioCryst Pharmaceuticals shares owned by BlackRock

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by BlackRock

Quarter filed Position value Share count Share price at filing
2025-09-30 $161M 21M 7.59
2025-06-30 $192M 21M 8.96
2025-03-31 $171M 23M 7.50
2024-12-31 $166M 22M 7.52
2024-09-30 $159M 21M 7.60